Actionable news
All posts from Actionable news
Actionable news in INO: Inovio Pharmaceuticals, Inc.,

AbbVie buys special review voucher for $350 million

AbbVie Inc has bought a priority review voucher from United Therapeutics Corp for $350 million that will allow it to accelerate the review process for one of its drugs.

United Therapeutics received a rare pediatric disease priority review voucher in March after its drug, Unituxin, was approved by the U.S. Food and Drug Administration to treat neuroblastoma, the company said on Wednesday.

The voucher, which offers a plethora of incentives, makes its holder eligible to have one of its drugs...